Graphitic carbon nitride nanosheets prepared by electrophoretic size fractionation as an anticancer agent against human bone carcinoma.
Antineoplastic Agents
/ therapeutic use
Bone Marrow Neoplasms
/ drug therapy
Cell Death
/ drug effects
Cell Line, Tumor
Cell Survival
/ drug effects
Chemical Fractionation
Electrophoresis
Graphite
/ chemistry
Humans
Male
Nanostructures
/ chemistry
Nitrogen Compounds
/ chemistry
Optical Phenomena
Spectrophotometry, Ultraviolet
Static Electricity
X-Ray Diffraction
Electrophoresis
anticancer agent
graphitic carbon nitride
nanosheets
size fractionation
Journal
Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
05
11
2019
revised:
04
02
2020
accepted:
02
03
2020
entrez:
14
4
2020
pubmed:
14
4
2020
medline:
8
1
2021
Statut:
ppublish
Résumé
Graphitic carbon nitride, g-C
Identifiants
pubmed: 32279787
pii: S0928-4931(19)34105-0
doi: 10.1016/j.msec.2020.110803
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Nitrogen Compounds
0
graphitic carbon nitride
0
Graphite
7782-42-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110803Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.